دورية أكاديمية
Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer
| العنوان: | Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer |
|---|---|
| المؤلفون: | Liu, Haonan, Pan, Di, Yao, Zhiyuan, Wang, Hongmei, Li, Yuqi, Qin, Xiaobing, Qu, Pengfei, Tang, Juanjuan, Han, Zhengxiang |
| المصدر: | In International Immunopharmacology 30 September 2024 139 |
| قاعدة البيانات: | ScienceDirect |
Full Text Finder | تدمد: | 15675769 |
|---|---|
| DOI: | 10.1016/j.intimp.2024.112635 |